In the first episode of our podcast Medicine Matters, Rosalind Campion from the Office for Life Sciences speaks to our host Diane DiGangi Trench about the critical role of generics and biosimilars. Catch this and future episodes as we delve into the collaboration between the off-patent

Our chief executive Mark Samuels gave evidence to the All-Party Pharmacy Group session on #MedicinesShortages. Mark spoke on why shortages are the tangible manifestation of a wider set of issues connected to the supply of generic and biosimilars. He also called for the off-patent sector

Rapid adoption of new biosimilar #medicines could save the #NHS more than £1 billion over the next five years, according to new guidance. As quoted in the The Pharmaceutical Journal, our Chief Executive Mark Samuels warns that the NHS could miss out on these savings if the Government

Congratulations to our Chief Executive Mark Samuels for being named in the list of Top 100 Influential People! Every year, the list recognises changemakers who are excelling in their field. Mark has been included for his role in advising the government on the off-patent sector, which has

The number of medicine supply shortages has been on a decline since September. February’s supply issues remained the same as January and totalled 73. Meanwhile, the number of discontinuations dropped off compared to last month. Access the dashboard: britishgenerics.co.uk/view-news/bgma…

We were thrilled to welcome Life Sciences Minister Baroness Gillian Merron at today's members' meeting. Her attendance underscores the vital contribution of generic medicines to the healthcare system and the #LifeSciences sector. Speaking to our members, she underlined the

We’re excited to be hosting an event to celebrate International Women's Day and the official launch of the BGMA Women’s Network. This year’s #IWD theme of “Accelerate Action” perfectly aligns with our commitment to improving #diversity and #inclusion in the off-patent sector.

To mark International Women’s Day later this week, we’re sharing another episode of our new podcast Medicine Matters. Join our host and association chair Diane DiGangi Trench as she sits downs with Clara Carter, UK country manager at Accord and the inaugural chair of the BGMA

For #IWD2025, Chair of our new Women's Network Clara Carter spoke to Generics Bulletin about how the network will help women thrive in the off-patent sector. "My vision for this network is to nurture a space that encourages our members to celebrate each other's achievements and

Today our members and representatives from the off-patent sector gathered in London for the official launch of our Women's Network. We were honoured to have Taiwo Owatemi MP join us as a special guest and participate on our panel discussion. She was joined by our Chief Executive

In the latest episode of our podcast Medicine Matters, Clara Carter, UK country manager at Accord Healthcare, shares her vision for the BGMA Women’s Network. In an in-depth conversation with Diane DiGangi Trench, they discuss why the network exists and how it will support women

Should security of supply trump innovation when it comes to our medicines? Our chief executive Mark Samuels writes for UK in a Changing Europe on why the new #LifeSciences Strategy needs to prioritise domestic supply of NHS #medicines when it publishes its future objectives. You can read

Our latest monthly dashboard offers an important and timely update on the number of generic medicine supply issues in England. In March, there was a gradual increase in generic supply issues, driven by the drop in originator on-patent product supply issues. However, total supply

Recent UK governments have focused their #LifeSciences strategies purely on innovation – ignoring security of supply which leaves patients vulnerable to increased risk of shortages. Writing in UK in a Changing Europe, our chief executive Mark Samuels explains why now more than ever the need

Heightened geopolitical tensions and trade frictions pose a threat to the UK's medicines security. Quoted in the Independent, our Chief Executive Mark Samuels says "it would make complete sense to treat the nation’s medicines supply like defence". Read the full story:

We are proudly launching our new name and brand as our association becomes Medicines UK. Our members supply the vast majority of prescription packs that the NHS relies on. Via off-patent competition, we create billions of pounds of savings allowing healthcare resources to go

The BGMA is now Medicines UK. Our new name reflects the scale of the contributions our members make to the overall medicines dispensed by the NHS. Our new brand reinvigorates our mission to create a sustainable and cost-effective supply of generic and biosimilar medicines to UK

In an uncertain world, we must prioritise the resilience and security of medicines supply. Read the comments of our chief executive Mark Samuels in inews: bit.ly/4ddBfe7